hiw3c 日报精选
The Decoder 网页快照

Isomorphic Labs在六个月内完成第二轮十亿美元级融资

原文标题 · Isomorphic Labs raises $5 billion in its second mega-round within six months

Isomorphic Labs已筹集了50亿美元资金,距离此前那笔21亿美元的轮次仅过了六个月。Alphabet的AI药物研发公司,由德米斯·哈萨比斯领导,计划利用这些资金将其药物管线推进至临床试验阶段。该公司目前尚未有获批的药物。该文章《Isomorphic Labs在六个月内完成第二笔大型轮次融资,筹集资金达50亿美元》最初发表于The Decoder上。

来源:The Decoder · the-decoder.com

正文为英文,可一键机器翻译(仅首次需要等待)

Isomorphic Labs raises $5 billion in its second mega-round within six months

Alphabet's AI drug discovery company Isomorphic Labs has raised $5 billion, its second billion-dollar round in six months. Greenoaks and Sequoia Capital co-led the round, joined by new backer Andreessen Horowitz along with Alphabet and all existing investors.

The company had already raised $2.1 billion back in May 2026. The money will go toward advancing its in-house platform IsoDDE (Isomorphic Drug Design Engine) and pushing its drug pipeline toward clinical trials. IsoDDE goes beyond AlphaFold 3, according to the company founded in 2021, and aims to better predict drug binding and docking sites. Isomorphic Labs works with Novartis, Eli Lilly, and Johnson & Johnson but has no approved drug to show for it yet.

The company is led by Demis Hassabis, who stepped down from day-to-day leadership of Google Deepmind in August 2026 and now serves as Alphabet's Chief Scientist. Hassabis won the 2024 Nobel Prize in Chemistry alongside John Jumper for their work on AlphaFold. Ad

Deepmind's original AlphaFold team was disbanded in July 2026 . Many researchers moved to Isomorphic Labs or were reassigned to other projects. Nearly a quarter left Deepmind entirely. Deepmind still shipped AlphaGenome 2 in early November 2026, which predicts how DNA variants affect gene activity in specific cell types. Ad

AI News Without the Hype – Curated by Humans

Subscribe to THE DECODER for ad-free reading, a weekly AI newsletter, our exclusive "AI Radar" frontier report six times a year, full archive access, and access to our comment section.